Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 29, 2011
CEI Senior Fellow Greg Conko discusses the FDA's pending decision on whether or not to withdraw its approval of Avastin as a treatment for breast cancer. Greg argues that because it is effective for a small proportion of breast cancer patients, they should be able to decide for themselves if they want to use it.